PFE vs QCOM: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
VS
QUALCOMM Incorporated · Technology
$201.97
-21.1% upside to fair value
Med Conviction
Grade D
High Quality
QuantHub Verdict
PFE has more upside to fair value
(+12.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
QCOM |
| Current Price |
$27.64 |
$201.97 |
| Fair Value Estimate |
$30.94 |
$159.42 |
| Upside to Fair Value |
+12.0%
|
-21.1%
|
| Market Cap |
$157.5B |
$212.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
17.4x
|
16.5x
|
| Price / Sales |
2.5x
|
4.8x
|
| Price / FCF |
14.3x
|
20.5x
|
| Revenue Growth YoY |
+2.6%
|
-4.0%
|
| Gross Margin |
71.3%
|
54.2%
|
| Operating Margin |
25.1%
|
23.2%
|
| Return on Equity |
4.9%
|
37.3%
|
| Dividend Yield |
6.22% |
1.79% |
| FCF Yield |
6.97%
|
4.88%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Qualcomm develops foundational wireless technologies and monetizes them through two main engines: QCT, which supplies Snapdragon application processors and modems, and QTL, which licenses a standards-essential patent portfolio covering CDMA2000, WCDMA, LTE and 5G. The licensing arm and the company's entrenched position in premium Android handsets give it a genuinely high-quality business, evidenc…
Accumulation Zones
| Metric |
PFE |
QCOM |
| Zone Low |
$23.21 |
$119.56 |
| Zone High |
$26.30 |
$135.51 |
| In Buy Zone? |
No
|
No
|